Abstract:
A cross-sectional study conducted during the period from January
2009 to December 2011 to determine and evaluate the plasma
levels of Malondialdehyde, antioxidants vitamins (A, E, C) and
selenium in Sudanese patients with type 2 diabetes mellitus. Two
hundred eighty five patients with type 2 diabetes mellitus were
selected as a test group from. The test group was compared with
the control group which included 100 apparently healthy
volunteers (non diabetics). Blood specimens were collected from
both groups, and plasma levels of Malondialdehyde, antioxidants
vitamins (A, E, C) and selenium, in addition to fasting plasma
glucose (FPG) and glycated hemoglobin (HbA1c) were
determined. Age and gender of the test group were matched with
the control group.
The results of this study indicate a significantly raised means of
the plasma levels of malondialdehyde, fasting plasma glucose,
and blood HbA1C of the test group when compared with healthy
control subjects, whereas the means of the plasma levels of
antioxidant vitamins (A, E, C), and selenium showed significant
reduction when compared with that of the control group.
The results of the present study indicate also significant
elevations of the mean of plasma levels of antioxidant vitamins
(A, E,) and selenium of the diabetic patients on multivitamins
when compared with those not taking multivitamins, and there is
significant reduction of the means of plasma levels of MDA, FPG,
and blood HbA1C% of the diabetic patients on multivitamins when
compared with those not taking multivitamins, where as there is
insignificant difference between the mean of plasma levels of
vitamin C between the two groups. Whereas there is insignificant
difference between the mean of plasma levels malondialdehyde,
antioxidant vitamins (A, E, C), selenium, fasting plasma glucose,
and blood HbA1C% of the diabetic patients on hypoglycemic
drugs and those on diet control.
The results of the current study indicate significant reduction of
the means of plasma levels of antioxidant vitamins (A, E, C) of the
diabetic
patients with hypertension when compared with
normotensive diabetic patients, where as there is insignificant
difference
between
the
means
of
plasma
levels
of
malondialdehyde, selenium, plasma fasting glucose, and blood
HbA1C between the two groups.
In this study there is insignificant difference between the means
of the plasmas levels of antioxidant vitamins (A, E, C), fasting
plasma glucose, and blood HbA1C of the diabetic patients with
ischemic heart disease and those without ischemic heart disease,
and there is significant increase in the mean of plasma levels of
malondialdehyde of patients with ischemic heart disease and
those without this disease, also there is significant decrease in the
mean of plasma levels of selenium of the patients with ischemic
heart disease and those without this disease.
The results of this study indicate significant strong positive
correlation between HbA1C percentage and fasting plasma
glucose (FPG), and significant negative correlation between
HbA1C and plasma selenium, whereas there is insignificant weak
positive correlation between HbA1C and plasma levels of
malondialdehyde, vitamin A, and vitamin C, also there is weak
negative correlation between HbA1C and vitamin E.
The current study indicate no correlation between the BMI and
plasma levels of MDA, selenium, vitamin A, vitamin E, FPG, and
HbA1C, and there is insignificant weak negative correlation
between the BMI and the plasma levels of vitamin C.
The results of the current study indicate no correlation between
the duration of disease (in years) and the plasma levels of MDA,
selenium, vitamin A, and vitamin C, and show weak positive
correlations between the duration of diabetes (in years) and
plasma levels of vitamin E, and HbA1C, also there is moderate
positive correlation between the duration of diabetes (in years)
and FPG, also the study showed insignificant negative correlation
between the duration of diabetes (in years) and the BMI.
In conclusion; the current study indicates that the plasma levels
of Malondialdehyde, antioxidants vitamins (A, E, C), selenium,
fasting plasma glucose, and glycated hemoglobin (HbA1c) are
important markers for evaluation of oxidative stress, antioxidants
status, and glycemic control of diabetic patients respectively, so
they can be used as prognostic markers for prediction of oxidative
stress, antioxidants status, and glycemic control of diabetic
patients especially in patients with complications such as
hypertension, ischemic heart disease, lipid abnormalities, and
uncontrolled diabetes.